
Gravian Pharmaceuticals Private Limited
Founded in 2008 and headquartered in Bihar, India.
Founded in 2008 and headquartered in Bihar, India.
Patna, Bihar, India
+91-XXXXXXXXXX
U51397BR2008PTC013603
013603
Private Limited Indian Non-Government Company
01 May 2008
17 Sep 2021
31 Mar 2021
Unlisted
Roc Patna
Name | Designation | Appointment Date | Status |
---|---|---|---|
Binita Mishra ![]() | Director | 01-May-2008 | Current |
Rakesh Mishra ![]() | Director | 01-May-2008 | Current |
Gravian Pharmaceuticals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
|
In 2016, Gravian Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Rakesh Mishra is a mutual person
Binita Mishra and Rakesh Mishra are mutual person
Binita Mishra is a mutual person
Rakesh Mishra is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Gravian Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Gravian Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gravian Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Gravian Pharmaceuticals Private Limited last Annual general meeting of members was held on 17 Sep 2021 as per latest MCA records.
Gravian Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Patna.
Binita Mishra was appointed as a Director was appointed as a Director on 01 May 2008 & has been associated with this company since 16 years 10 months .
Rakesh Mishra was appointed as a Director was appointed as a Director on 01 May 2008 & has been associated with this company since 16 years 10 months .
Gravian Pharmaceuticals Private Limited was registered on 01 May 2008 with Roc Patna & aged 16 years 10 months as per MCA records.
Gravian Pharmaceuticals Private Limited was incorporated on 01 May 2008.
The authorized share capital of Gravian Pharmaceuticals Private Limited is ₹ 0.20 M and paid-up capital is ₹ 0.20 M.
Currently 2 directors are associated with Gravian Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Gravian Pharmaceuticals Private Limited is 201 2Nd Floor Rajendra Ram Plaza Exhibition Road, India, Patna, Bihar, 800001.
The corporate identification number (CIN) of Gravian Pharmaceuticals Private Limited is U51397BR2008PTC013603 and the company number is 013603 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Gravian Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2021.